AlloSource distributes first bioengineered vessels for Humacyte clinical trials

AlloSource distributes first bioengineered vessels for Humacyte clinical trials

CENTENNIAL -- AlloSource , one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient... Read More

Tuesday May 24, 2016 0 comments Tags: AlloSource, Centennial, Thomas Cycyota, Humacyte, Carrie Cox

IN Sponsors

Content Garden ad

Browse

Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19
Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19
Waterpik unveils new line of massage shower heads
Waterpik unveils new line of massage shower heads
Everyone’s a leader?
Everyone’s a leader?
Robots and automation will never fully replace humans. And that’s a good thing.
Robots and automation will never fully replace humans. And that’s a good thing.
ColdQuanta UK awarded $3.5M to commercialize new quantum technologies
ColdQuanta UK awarded $3.5M to commercialize new quantum technologies

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.